Sponsor Pipeline

Verrica Pharmaceuticals Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
3
Phase 3
Active Trials by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07246590 Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) Common Warts Recruiting
NCT07457918 Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common… Common Warts (Verruca Vulgaris) Recruiting
NCT07637734 Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) Common Warts Not Yet Recruiting
Get alerts when Verrica Pharmaceuticals Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free